The injection of T in the BPH model induces excessive inflammation and weakens cellular antioxidant mechanisms [1], which may explain the lower CAT and SOD contents in prostate cells in the BPH group compared with those in the Ctrl group. The gene discussed is SOD1; the disease is benign prostatic hyperplasia.